Tennessee HB1984 amends regulations on buprenorphine product use, allowing certain exceptions for dispensing without naloxone.
Tennessee HB1984 amends Tennessee Code Annotated, Title 53, Chapter 11, to modify the use of buprenorphine products. It allows buprenorphine without naloxone to be dispensed to specific groups, including pregnant women, nursing mothers, patients with a history of adverse reactions, or hypersensitivity. The bill also permits healthcare providers to directly administer buprenorphine mono or without naloxone for treating substance use disorder, provided it is within their scope of practice and pursuant to a medical order or prescription. This act takes effect immediately upon becoming law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.